Results were slightly above prior year but revenue was flat and no guidance was provided. The stock may trade sideways. Watch for completion of the Miller Medical Plaza development (expected Q4 2026) as a potential catalyst.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 28 $40.80entry
- T+1 · 7mo ago −0.82%α −0.81% · $40.47
- T+5 · 7mo ago −2.30%α −4.00% · $39.86
- T+20 · 6mo ago +3.11%α −2.36% · $42.07
- T+60 · 4mo ago +6.10%α +2.11% · $43.29
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
UHT reported Q1 2026 net income of $5.0M ($0.36/diluted share), up from $4.8M ($0.34) a year ago, driven by lower interest expense. FFO increased to $0.88/diluted share from $0.86. Revenue was essentially flat at $24.5M. The modest beat lacked guidance, so the report is unlikely to move the stock significantly.
Key Financial Metrics
Key Facts
- Q1 2026 net income $5.0M vs $4.8M in Q1 2025
- FFO per diluted share $0.88 vs $0.86 year-over-year
- Revenue $24.5M, virtually unchanged from $24.5M
- Quarterly dividend maintained at $0.745 per share
- Credit line increased to $475M from $425M in April 2026
Financial Impact
Net income up $242K (5.1%), FFO up $336K (2.3%), revenue down $19K (0.1%)
Risk Factors
- Interest rate increases could pressure borrowing costs
- Healthcare policy changes (Medicaid funding) may affect tenant operations
- Concentration risk with UHS as a major tenant
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-182162 |
| Document: uht-20260427.htm | 0001193125-26-182162 |
| Document: 0001193125-26-182162-index-headers.html | 0001193125-26-182162 |
| Document: 0001193125-26-182162-index.html | 0001193125-26-182162 |
| Document: 0001193125-26-182162.txt | 0001193125-26-182162 |
| 8-K Data (Synthetic) | 0001193125-26-182162 |
Track record
5 reports on UHT
The track record builds as more bullish or bearish reports settle.
Filters
- Oct 27, 202620d ago 8-K Neutral 4/10 Entry $36.76 Now $38.83 +5.63% settles Jan 26
- Apr 28, 202628w ago DEFA14A Neutral 2/10 Entry $40.80 to $43.29 Now $38.83 −4.83% ▲ +6.10% +2.11% vs SPY
- Apr 27, 202629w ago 8-K Neutral 3/10 Viewing Entry $40.80 to $43.29 Now $38.83 −4.83% ▲ +6.10% +2.11% vs SPY
- Apr 24, 202629w ago 8-K Neutral 4/10 Entry $40.77 to $43.88 Now $38.83 −4.76% ▲ +7.63% +2.55% vs SPY
- Feb 25, 202637w ago 8-K Bearish 6/10 Entry $43.38 to $42.12 Now $38.83 +10.48% ▲ +2.90% +10.65% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers